© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
Cristina Gasparetto, MD, is joined by her patient, Donna, as they discuss her particular experience with diagnosis and treatment of multiple myeloma.
May 21st 2021
Cristina Gasparetto, MD, gives a brief overview of the multiple myeloma disease state and introduces us to Donna, one of her patients diagnosed with multiple myeloma.
Donna discusses her multiple myeloma diagnosis and the start of her treatment, while Dr Gasparetto educates on the importance of transplants.
We learn more about Donna’s 2 transplants, her chemotherapy, and how they impacted her quality of life.
Cristina Gasparetto, MD, details typical multiple myeloma maintenance in comparison with Donna’s therapies, and Donna tells us about her first relapse with multiple myeloma.
Donna and Dr Gasparetto converse about the many first- and second-line therapies for multiple myeloma.
Cristina Gasparetto, MD, discusses Donna’s relationship with the drug carfilzomib for multiple myeloma therapy, as well as her second relapse.
May 27th 2021
Donna’s multiple myeloma treatment changes with the help of Dr Cristina Gasparetto’s direct influence and CAR T cell therapy.
Cristina Gasparetto, MD, discusses Donna’s next line of therapy, selinexor, and how being part of a clinical trial impacted her multiple myeloma.
June 2nd 2021
Donna gives advice to other multiple myeloma patients about what she has learned from living with this disease and her various therapies.
Donna and Dr Gasparetto close the discussion by highlighting the importance of physicians utilizing their patients, as well as patients being involved with their multiple myeloma treatment.
Act Fast: Side Effects of Immunotherapy
CNN Anchor Christiane Amanpour Receiving Treatment for Ovarian Cancer
Standing Firm Against the Financial Burden of Cancer
Yescarta Associated With Better Outcomes Than Other Available Treatments for Relapsed/Refractory Follicular Lymphoma